Skip to content

SEDICAN: Sex differences in the acute effects of cannabis

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505159-35-00
Acronym
2023-505159-35-00
Enrollment
54
Registered
2024-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A - healthy volunteers

Interventions

None listed

Sponsors

Bedrocan International B.V.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026